Net sales exceeded guidance by 93 million yen versus the previous forecast, and operating income, ordinary income, and interim net income also exceeded guidance. There is no change to the full-year earnings guidance at this time. A portion of selling expenses was capitalized as fixed assets, contributing to expense reduction. Domestic sales are solid.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6678","jir_company_name":"Techno Medica Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-06","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/6678-20261106-02.pdf","jir_short_summary":"Net sales exceeded guidance by 93 million yen versus the previous forecast, and operating income, ordinary income, and interim net income also exceeded guidance. There is no change to the full-year earnings guidance at this time. A portion of selling expenses was capitalized as fixed assets, contributing to expense reduction. Domestic sales are solid.","jir_summary":"### Overview of Results\nFor the second quarter of the fiscal year ending March 2027, results were net sales of 4,453 million yen, operating income of 468 million yen, ordinary income of 485 million yen, and interim net income of 321 million yen, exceeding the previous guidance. Net sales exceeded guidance due to strong domestic sales of blood collection tube preparation equipment\/systems and specimen testing devices, and on the expense side, selling, general and administrative expenses decreased due to capitalization of a portion of R&D expenses as fixed assets, causing profit metrics to surpass guidance. There is no revision to the full-year earnings guidance at this time.\n\n### Outlook and Factors\nAlthough there is no change to the full-year guidance at present, the strong sales trend in the first half and the impact of expense treatment may continue to contribute positively to profits. The foreign exchange impact is unclear based only on the provided rate information, but strengthened domestic sales are expected to continue supporting performance.","jir_financial_highlights":"Net sales: 4,453 (Previous guidance 4,360 \u2192 Actual 4,453 million yen Increase 93)\nOperating income: 468 (Previous guidance 300 \u2192 Actual 468 million yen Increase 168)\nOrdinary income: 485 (Previous guidance 310 \u2192 Actual 485 million yen Increase 175)\nInterim net income: 321 (Previous guidance 220 \u2192 Actual 321 million yen Increase 101)\nInterim net income per share: 48.94 (Previous guidance 31.90 \u2192 Actual 48.94 yen Increase Unknown)","jir_category":"","jir_hashtags":"#TechnoMedica, #EarningsAnnouncement, #InterimResults","jir_key_figures":"Net sales: 4,453 million yen\nOperating income: 468 million yen\nOrdinary income: 485 million yen\nInterim net income: 321 million yen\nInterim net income per share: 48.94 yen","jir_meta_title":"Techno Medica Co., Ltd. \u2014 FY2027 Q2 Interim Results | Sales and Profits Exceed Guidance","jir_meta_description":"Techno Medica Co., Ltd. announced FY2027 Q2 interim results: net sales 4,453 million yen, operating income 468 million yen, interim net income 321 million yen. No revision to full-year guidance at this time. Solid domestic sales and capitalization of certain expenses contributed.","jir_og_title":"Techno Medica Co., Ltd. \u2014 FY2027 Q2 Interim Results Exceed Guidance","jir_og_description":"Techno Medica Co., Ltd.'s Q2 interim results saw sales and profits exceed guidance. Revision to full-year guidance is TBD. Solid domestic market performance drove results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":57947,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-144101","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n